Chronic myelogenous leukemia other diagnostic studies

Revision as of 15:11, 31 July 2018 by SimaNoor (talk | contribs)
Jump to navigation Jump to search

Reverse transcriptase (RT) PCR


Chronic myelogenous leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic myelogenous leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic myelogenous leukemia other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic myelogenous leukemia other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic myelogenous leukemia other diagnostic studies

CDC on Chronic myelogenous leukemia other diagnostic studies

Chronic myelogenous leukemia other diagnostic studies in the news

Blogs on Chronic myelogenous leukemia other diagnostic studies

Directions to Hospitals Treating Chronic myelogenous leukemia

Risk calculators and risk factors for Chronic myelogenous leukemia other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Other diagnostic studies for chronic myelogenous leukemia include bone marrow aspiration and biopsy, lumbar puncture, and lymph node biopsy. Genomic PCR, Southern blot assay, Reverse transcriptase (RT) PCR, Northern blot analysis, Western blot analysis or immunoprecipitation can be helpful in the diagnosis of chronic myelogenous leukemia; the gold standard diagnostic test in chronic myelogenous leukemia is cytogenetic analysis.[1] [2]

Other diagnostic studies

Other diagnostic studies for chronic myelogenous leukemia include:[3]

  • Used to detect and/or determine the type of leukemic cells
  • Lymph node biopsy
    • Used to detect and/or determine the type of leukemic cells
  • Genomic PCR
    • can determine the exact breakpoints of the fusion genes
  • Southern blot assay
    • can determine the exact breakpoints of the fusion genes
  • Reverse transcriptase (RT) PCR
    • detect BCR-ABL transcripts at the RNA level
  • Northern blot analysis
    • detect BCR-ABL transcripts at the RNA level
  • Western blot analysis
    • demonstrate the p210bcr-abl protein by using monoclonal antibodies against Bcr and Abl
  • Immunoprecipitation
    • demonstrate the p210bcr-abl protein by using monoclonal antibodies against Bcr and Abl

Gallery

References

  1. Faderl S, Talpaz M, Estrov Z, Kantarjian HM (August 1999). "Chronic myelogenous leukemia: biology and therapy". Ann. Intern. Med. 131 (3): 207–19. PMID 10428738.
  2. von Bubnoff N, Duyster J (February 2010). "Chronic myelogenous leukemia: treatment and monitoring". Dtsch Arztebl Int. 107 (7): 114–21. doi:10.3238/arztebl.2010.0114. PMC 2835925. PMID 20221270.
  3. Canadian Cancer Society.2015.http://www.cancer.ca/en/cancer-information/cancer-type/leukemia-chronic-myelogenous-cml/diagnosis/?region=ab
  4. National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/leukemia/patient/cml-treatment-pdq


Template:WikiDoc Sources